Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategies used by people who inject drugs to avoid stigma in healthcare settings
Dea L. Biancarelli, Katie B. Biello, Ellen Childs, et al.
Drug and Alcohol Dependence (2019) Vol. 198, pp. 80-86
Open Access | Times Cited: 395

Showing 1-25 of 395 citing articles:

Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Alexander C. Tsai, Mathew V. Kiang, Michael L. Barnett, et al.
PLoS Medicine (2019) Vol. 16, Iss. 11, pp. e1002969-e1002969
Open Access | Times Cited: 319
“They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City
Brandon Muncan, Suzan M. Walters, Jerel M. Ezell, et al.
Harm Reduction Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 287
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Tom H. Karlsen, Nick Sheron, Shira Zelber‐Sagi, et al.
The Lancet (2021) Vol. 399, Iss. 10319, pp. 61-116
Open Access | Times Cited: 170
Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism
Hortensia Amaro, Mariana Sánchez, Tara G. Bautista, et al.
Neuropharmacology (2021) Vol. 188, pp. 108518-108518
Open Access | Times Cited: 162
Integrated Hepatitis C–Opioid Use Disorder Care Through Facilitated Telemedicine
Andrew H. Talal, Marianthi Markatou, Anran Liu, et al.
JAMA (2024) Vol. 331, Iss. 16, pp. 1369-1369
Closed Access | Times Cited: 23
Substance Use Disorders and COVID-19: Multi-Faceted Problems Which Require Multi-Pronged Solutions
Wossenseged Birhane Jemberie, Jennifer Stewart Williams, Malin Eriksson, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 105
Responding to Outbreaks of Human Immunodeficiency Virus Among Persons Who Inject Drugs—United States, 2016–2019: Perspectives on Recent Experience and Lessons Learned
Sheryl Lyss, Kate Buchacz, R. Paul McClung, et al.
The Journal of Infectious Diseases (2020) Vol. 222, Iss. Supplement_5, pp. S239-S249
Open Access | Times Cited: 91
“Health Is on the Back Burner:” Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs
Delia Motavalli, Jessica L. Taylor, Ellen Childs, et al.
Journal of General Internal Medicine (2020) Vol. 36, Iss. 1, pp. 129-137
Open Access | Times Cited: 84
“You’re kind of at war with yourself as a nurse”: Perspectives of inpatient nurses on treating people who present with a comorbid opioid use disorder
Gabrielle Horner, Jeff Daddona, Deirdre Burke, et al.
PLoS ONE (2019) Vol. 14, Iss. 10, pp. e0224335-e0224335
Open Access | Times Cited: 78
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019
Beth E. Meyerson, Danielle M. Russell, Michaela Kichler, et al.
International Journal of Drug Policy (2021) Vol. 93, pp. 103112-103112
Open Access | Times Cited: 71
Accessible Hepatitis C Care for People Who Inject Drugs
Benjamin Eckhardt, Pedro Mateu‐Gelabert, Yesenia Aponte-Meléndez, et al.
JAMA Internal Medicine (2022) Vol. 182, Iss. 5, pp. 494-494
Open Access | Times Cited: 48
Reducing the harms of xylazine: clinical approaches, research deficits, and public health context
Claire M. Zagorski, Rebecca A. Hosey, Christopher Moraff, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 40
Emergency department experiences of people who use drugs who left or were discharged from hospital against medical advice
Samara Mayer, Verena Langheimer, Seonaid Nolan, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0282215-e0282215
Open Access | Times Cited: 24
Safer opioid supply: qualitative program evaluation
Marlene Haines, Patrick O’Byrne
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Experiences of stigma and subsequent reduced access to health care among women who inject drugs
Loren Brener, Elena Cama, Timothy R. Broady, et al.
Drug and Alcohol Review (2024) Vol. 43, Iss. 5, pp. 1071-1079
Open Access | Times Cited: 10
Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl
Honora Englander, Ashish P. Thakrar, Sarah M. Bagley, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 6, pp. 691-691
Closed Access | Times Cited: 10
Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowledge
Daniel J. Bromberg, Eteri Machavariani, Lynn M. Madden, et al.
Journal of the International AIDS Society (2024) Vol. 27, Iss. 2
Open Access | Times Cited: 8
Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts
Simeon D. Kimmel, Sophie Rosenmoss, Benjamin Bearnot, et al.
Journal of Addiction Medicine (2020) Vol. 15, Iss. 1, pp. 20-26
Open Access | Times Cited: 60
Conceptualizing stigma in contexts of pregnancy and opioid misuse: A qualitative study with women and healthcare providers in Ohio
Jennifer L. Syvertsen, Hannah Toneff, Heather Howard, et al.
Drug and Alcohol Dependence (2021) Vol. 222, pp. 108677-108677
Closed Access | Times Cited: 54
Refusal to accept emergency medical transport following opioid overdose, and conditions that may promote connections to care
Rachel Bergstein, Kelly M. King, G. J. Meléndez‐Torres, et al.
International Journal of Drug Policy (2021) Vol. 97, pp. 103296-103296
Closed Access | Times Cited: 43
Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region
Steffanie A. Strathdee, Daniela Abramovitz, Alicia Vera, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e726-e733
Open Access | Times Cited: 43
Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study
Lars Garpenhag, Disa Dahlman
Substance Abuse Treatment Prevention and Policy (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 42
Uptake of COVID-19 vaccination among people who inject drugs
Jenny Iversen, Handan Wand, Robert Kemp, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 37
Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities
Suzan M. Walters, David C. Perlman, Honoria Guarino, et al.
Substance Use & Misuse (2022) Vol. 57, Iss. 7, pp. 1144-1153
Open Access | Times Cited: 33
A scoping review of qualitative research on barriers and facilitators to the use of supervised consumption services
Andrew Ivsins, Ashley Warnock, Will Small, et al.
International Journal of Drug Policy (2022) Vol. 111, pp. 103910-103910
Closed Access | Times Cited: 33
Page 1 - Next Page

Scroll to top